Latest News & Updates
Breaking News
4 hours ago
Simantini Singh Deo
Other trending news you may like to read
FDA Sends Complete Response Letter To Sanofi, Delaying Approval of Tolebrutinib For Non-Relapsing SPMS Until More Information Is Provided
Sanofi receives an FDA complete response letter for tolebrutinib in nrSPMS, delaying U.S. approval as discussions continue.
Simantini Singh Deo
Sanofi To Acquire Dynavax For $2.2 Billion, Adding HEPLISAV-B Hepatitis B Vaccine And Z-1018 Shingles Candidate To Its Adult Immunization Portfolio
Sanofi to acquire Dynavax for about $2.2 billion, strengthening its adult vaccines portfolio with HEPLISAV-B and a shingles vaccine candidate.
Simantini Singh Deo
Vor Bio Announces Board Appointments Of Andrew Levin, M.D., Ph.D., And Forbion’s Wouter Joustra
Vor Biopharma adds Andrew Levin and Wouter Joustra to its Board, strengthening investment and governance expertise as Phase 3 programs advance.
Simantini Singh Deo
Pelthos Therapeutics Strengthens Leadership Team, Appoints Andrew Einhorn To Board Of Directors
Pelthos appoints Andrew Einhorn to its Board of Directors, adding over four decades of financial and life sciences leadership.
Simantini Singh Deo
